Literature DB >> 25596095

Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2.

Yao-Guang Li1, Jie Hou2, Shi-Yang Li3, Xia Lv3, Jing Ning4, Ping Wang3, Zhao-Ming Liu3, Guang-Bo Ge5, Jia-Yan Ren6, Ling Yang7.   

Abstract

Fructus Psoraleae (FP) is an edible Chinese herbal which is widely used in Asia for the treatment of various diseases including asthma, diarrhea, and osteoporosis. This study aimed to investigate the inhibitory effects of the crude ethanol extract from FP on human carboxylesterase 2 (hCE2), as well as to identity and characterize the naturally occurring inhibitors of hCE2 in FP. Our results demonstrated that the ethanol extract of FP displayed potent inhibitory effects towards hCE2, while five major bioactive constitutes in FP were efficiently identified by LC-DAD-ESI-MS/MS, with the aid of LC-based activity profiling. The identified bioactive compounds including neobavaisoflavone, isobavachalcone, bavachinin, corylifol A and bakuchiol were found to be naturally occurring potent inhibitors of hCE2, with low Ki values ranging from 0.62μM to 3.89μM. This is the first report of the chemical constitutes in FP as potent inhibitors of hCE2.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fructus Psoraleae; Human carboxylesterase 2; Inhibitory effects; LC-DAD-ESI-MS/MS

Mesh:

Substances:

Year:  2015        PMID: 25596095     DOI: 10.1016/j.fitote.2015.01.004

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   3.204


  17 in total

1.  Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells.

Authors:  Yang Li; Jinjin Xu; Chunxia Xu; Zifei Qin; Shishi Li; Liufang Hu; Zhihong Yao; Frank J Gonzalez; Xinsheng Yao
Journal:  Xenobiotica       Date:  2020-04-01       Impact factor: 1.908

2.  In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.

Authors:  Jinjin Xu; Mengsen Li; Zhihong Yao; Yezi Zhang; Shishi Li; Liufang Hu; Zifei Qin; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Biomed Anal       Date:  2018-06-18       Impact factor: 3.935

3.  Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.

Authors:  Xinqiang Li; Han Xing; Zifei Qin; Jing Yang; Peile Wang; Xiaojian Zhang; Zhihong Yao; Xinsheng Yao
Journal:  RSC Adv       Date:  2020-09-23       Impact factor: 4.036

4.  Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.

Authors:  Haoran Jing; Shaoxia Wang; Min Wang; Wenliang Fu; Chao Zhang; Donggang Xu
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1.

Authors:  Li-Wei Zou; Tong-Yi Dou; Ping Wang; Wei Lei; Zi-Miao Weng; Jie Hou; Dan-Dan Wang; Yi-Ming Fan; Wei-Dong Zhang; Guang-Bo Ge; Ling Yang
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

Review 6.  Herbal Compounds Play a Role in Neuroprotection through the Inhibition of Microglial Activation.

Authors:  Yan Fu; Jianmei Yang; Xingyu Wang; Pin Yang; Yang Zhao; Kun Li; Yongjun Chen; Ying Xu
Journal:  J Immunol Res       Date:  2018-04-17       Impact factor: 4.818

7.  Synthesis and Evaluation of Bakuchiol Derivatives as Potential Anticancer Agents.

Authors:  Cheng-Zhu Wu; Da-Chuan Liu; Xing Guo; Yiqun Dai; Tao Ma; Hong-Mei Li; Qiang Huo
Journal:  Molecules       Date:  2018-02-26       Impact factor: 4.411

8.  Phytoestrogen Bakuchiol Exhibits In Vitro and In Vivo Anti-breast Cancer Effects by Inducing S Phase Arrest and Apoptosis.

Authors:  Li Li; Xueping Chen; Chi C Liu; Lai S Lee; Cornelia Man; Shuk H Cheng
Journal:  Front Pharmacol       Date:  2016-05-24       Impact factor: 5.810

9.  Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1.

Authors:  Xuewei Cheng; Xia Lv; Hengyan Qu; Dandan Li; Mengmeng Hu; Wenzhi Guo; Guangbo Ge; Ruihua Dong
Journal:  Acta Pharm Sin B       Date:  2017-09-01       Impact factor: 11.413

Review 10.  Human carboxylesterases: a comprehensive review.

Authors:  Dandan Wang; Liwei Zou; Qiang Jin; Jie Hou; Guangbo Ge; Ling Yang
Journal:  Acta Pharm Sin B       Date:  2018-06-25       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.